AGMB · Agomab Therapeutics NV
$13.88
-0.40 (-2.80%)
At close · Aug 27
Market Cap
$703.26M
Shares
49.25M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
No structured figures reported for this view yet.
Key facts
CIK
2020932
CUSIP
00860C102
13F (30d)
31 filings
31 filers
Visit website
Investor relations